The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 352:506-508 February 3, 2005 Number 5
NextNext

Double Trouble for Type 1 Angiotensin Receptors in Atherosclerosis
Walter G. Thomas, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
G protein–coupled receptors represent the largest superfamily of receptors in the human genome. They are intricate sensors and transducers and are fundamental to physiology and disease. Drugs that target these receptors have therapeutic utility and potential and include beta-blockers and blockers of type 1 angiotensin (AT1) receptors. Traditionally, G protein–coupled receptors were thought to act as monomers, in which one ligand binds and activates a single receptor–G protein complex. Newer evidence,1 however, points to the existence of higher-order complexes (dimers or oligomers) with altered pharmacology, responsiveness, or both.2,3 A recent report by AbdAlla and colleagues4 not only underscores the . . . [Full Text of this Article]


Source Information

From the Baker Heart Research Institute, Melbourne, Australia.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.